Browsing by Author Bruner, J. M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 12 to 21 of 21 < previous 
TitleAuthor(s)Issue date???itemlist.???
Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survivalPuduvalli, V. K.; Kyritsis, A. P.; Hess, K. R.; Bondy, M. L.; Fuller, G. N.; Kouraklis, G. P.; Levin, V. A.; Bruner, J. M.24-Nov-2015-
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiformeGroves, M. D.; Maor, M. H.; Meyers, C.; Kyritsis, A. P.; Jaeckle, K. A.; Yung, W. K.; Sawaya, R. E.; Hess, K.; Bruner, J. M.; Peterson, P.; Levin, V. A.24-Nov-2015-
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiformeLevin, V. A.; Uhm, J. H.; Jaeckle, K. A.; Choucair, A.; Flynn, P. J.; Yung, W. K. A.; Prados, M. D.; Bruner, J. M.; Chang, S. M.; Kyritsis, A. P.; Gleason, M. J.; Hess, K. R.24-Nov-2015-
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomasLevin, V. A.; Hess, K. R.; Choucair, A.; Flynn, P. J.; Jaeckle, K. A.; Kyritsis, A. P.; Yung, W. K.; Prados, M. D.; Bruner, J. M.; Ictech, S.; Gleason, M. J.; Kim, H. W.24-Nov-2015-
Prognostic significance of p53 immunoreactivity in patients with gliomaKyritsis, A. P.; Bondy, M. L.; Hess, K. R.; Cunningham, J. E.; Zhu, D.; Amos, C. J.; Yung, W. K.; Levin, V. A.; Bruner, J. M.24-Nov-2015-
Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomasWei, Q.; Bondy, M. L.; Mao, L.; Gaun, Y.; Cheng, L.; Cunningham, J.; Fan, Y.; Bruner, J. M.; Yung, W. K.; Levin, V. A.; Kyritsis, A. P.24-Nov-2015-
Risk assessment for developing gliomas: a comparison of two cytogenetic approachesEl-Zein, R.; Bondy, M. L.; Wang, L. E.; de Andrade, M.; Sigurdson, A. J.; Bruner, J. M.; Kyritsis, A. P.; Levin, V. A.; Wei, Q.24-Nov-2015-
Suppression of human glioma growth by adenovirus-mediated Rb gene transferFueyo, J.; Gomez-Manzano, C.; Yung, W. K.; Liu, T. J.; Alemany, R.; Bruner, J. M.; Chintala, S. K.; Rao, J. S.; Levin, V. A.; Kyritsis, A. P.24-Nov-2015-
TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activationPuduvalli, V. K.; Sampath, D.; Bruner, J. M.; Nangia, J.; Xu, R.; Kyritsis, A. P.24-Nov-2015-
The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2BKaba, S. E.; DeMonte, F.; Bruner, J. M.; Kyritsis, A. P.; Jaeckle, K. A.; Levin, V.; Yung, W. K.24-Nov-2015-